Published in Aging Dis on February 01, 2017
Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol (2005) 4.96
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience (1990) 4.52
Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest (2008) 2.91
Glial reactions in Parkinson's disease. Mov Disord (2008) 2.62
Oxidative stress and inflammation in Parkinson's disease: is there a causal link? Exp Neurol (2005) 1.82
Priorities in Parkinson's disease research. Nat Rev Drug Discov (2011) 1.66
Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease. Clin Neurosci Res (2006) 1.50
Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Mov Disord (2006) 1.49
Neurotoxin-based models of Parkinson's disease. Neuroscience (2011) 1.46
Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives. Lancet (2014) 1.46
Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience (1995) 1.37
Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease. PLoS One (2010) 1.29
Inflammation and adaptive immunity in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 1.22
Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model. J Neurosci Methods (2006) 1.20
Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8). Acta Pharmacol Sin (2012) 1.17
Functional properties of the basal ganglia's re-entrant loop architecture: selection and reinforcement. Neuroscience (2011) 1.13
Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro (2013) 1.05
The role of innate and adaptive immunity in Parkinson's disease. J Parkinsons Dis (2013) 1.03
The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes. Mol Neurobiol (2013) 1.02
Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection. Neurobiol Dis (2005) 0.99
Innate inflammation in Parkinson's disease. Cold Spring Harb Perspect Med (2012) 0.96
FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease. Neurobiol Aging (2015) 0.90
Triptolide with potential medicinal value for diseases of the central nervous system. CNS Neurosci Ther (2012) 0.89
Inflammatory mediators as biomarkers in brain disorders. Inflammation (2014) 0.86
Immune responses in Parkinson's disease: interplay between central and peripheral immune systems. Biomed Res Int (2014) 0.86
Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair. Int J Neurosci (2015) 0.84
Pathways towards an effective immunotherapy for Parkinson's disease. Expert Rev Neurother (2011) 0.84
Use of 6-hydroxydopamine to create lesions in catecholamine neurons in rats. J Neurosurg (1975) 0.83
Tenuigenin protects dopaminergic neurons from inflammation-mediated damage induced by the lipopolysaccharide. CNS Neurosci Ther (2012) 0.81
Autoimmunity, dendritic cells and relevance for Parkinson's disease. J Neural Transm (Vienna) (2012) 0.81
Forced exercise before or after induction of 6-OHDA-mediated nigrostriatal insult does not mitigate behavioral asymmetry in a hemiparkinsonian rat model. Brain Res (2013) 0.80
Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway. Neuropharmacology (2012) 0.79